• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchHelix Biopharma
    Picture of Helix Biopharma logo

    HBP — Helix Biopharma Share News

    CA$0.990.000.00%
    ca flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      CA$75.61m
    • Enterprise Value
      CA$73.13m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • HBP Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    HBP Dividends
    • Brief: Helix Biopharma initiates enrollment in second dosing of lung cancer drug candidate

      21/01/2016 21:36
    • Brief: Helix Biopharma appoints Zbigniew Markowski as CEO

      12/01/2016 13:01
    • Brief: Helix Biopharma Q1 loss per share C$0.03

      11/12/2015 22:42
    • Brief: Helix Biopharma names Gary Littlejohn interim CEO

      29/10/2015 20:57
    • Poland - Factors to Watch Oct 9

      09/10/2014 07:02
    Previous1234Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.